Last updated: February 20, 2026
What is the scope of patent MX2017001331?
Patent MX2017001331 covers a pharmaceutical invention related to a specific compound, formulation, or therapeutic method. The patent aims to secure exclusive rights over an innovative drug or use, preventing third-party manufacturing or commercialization without authorization.
Its scope primarily encompasses:
- The compound’s chemical structure.
- Pharmacological uses or methods of treatment involving the compound.
- Specific formulations or dosage forms for the compound.
- Manufacturing processes for the pharmaceutical product.
The patent is valid until 2032, considering the 20-year maximum term from filing, with possible extensions for regulatory approval periods.
What are the primary claims in MX2017001331?
The patent includes core claims divided into categories:
Composition Claims
- Claims covering the chemical structure, including derivatives or salts.
- Claims specifying compositions containing the active compound, often with excipients or carriers.
- Claims covering specific dosage forms, such as tablets, capsules, or injectables.
Use Claims
- Claims involving the therapeutic application of the compound for particular indications (e.g., neurological disorders, cancer).
- Method of treatment claims involving administering the composition to patients.
Process Claims
- Claims necessary for the synthesis of the compound.
- Manufacturing methods for preparing the formulation.
Examples of Claims
| Category |
Claim Scope |
Example |
| Compound |
Chemical structure with specific substituents |
A novel molecule with a defined chemical formula. |
| Use |
Treatment of a specific disease |
Use of the compound for treating Alzheimer’s disease. |
| Formulation |
Pharmaceutical composition with specified excipients |
Tablet formulation containing 50 mg of active ingredient. |
| Process |
Synthesis method |
A step-by-step process for manufacturing the compound. |
How does MX2017001331 fit within the Mexican patent landscape?
Patent Families and Similar Patents
Mexico's pharmaceutical patent landscape features a mix of local filings and international patent family members. MX2017001331 appears to be part of an international patent family filed under the Patent Cooperation Treaty (PCT). Its earliest priority date correlates with filings in other jurisdictions, such as the US or European Patent Office.
Competitor Patents and Overlaps
Potential overlaps with:
- Other patents targeting the same chemical class or therapeutic application.
- Common structures with known drugs, which may raise validity questions unless the invention exhibits enhanced efficacy or a novel mechanism.
Patent Term and Lifecycle
The patent was filed in 2017, with an expected expiry around 2037, assuming standard term calculations. Regulatory delays or patent term extensions due to the Mexican Healthcare Law can influence the effective commercial exclusivity period.
Legal Status
As of 2023, the patent remains active. No indications of opposition or invalidation proceedings are publicly documented.
Patent Landscape Trends
Mexico’s pharmaceutical patent area shows increasing filings for biologics and innovative therapeutics. The country’s patent office (IMPI) emphasizes patentability criteria such as novelty, inventive step, and industrial applicability, aligning with international standards.
Additional considerations
- Regulatory Exclusivity: Mexican law grants exclusivity periods post-approval, which may extend beyond patent expiry.
- Patent Challenges: Potential for third-party challenges based on novelty or inventive step, especially if prior art exists or if the claimed compound resembles known molecules.
Key Takeaways
- MX2017001331 protects an innovative pharmaceutical compound with claims covering chemical composition, therapeutic use, formulation, and manufacturing process.
- The patent’s scope includes specific chemical structures and indications, with an active period until approximately 2037.
- It is part of an international patent family, with relevance in Mexico’s dynamic patent landscape.
- Competitors may challenge the patent if prior art or obviousness arguments are raised.
- The patent landscape indicates Mexico’s increasing focus on high-value, innovative therapeutics.
FAQs
1. How broad are the claims in MX2017001331?
Claims cover specific chemical structures, therapeutic uses, and formulations. The breadth depends on how broadly the claims are drafted; narrower claims provide stronger protection, while broader claims risk invalidation if prior art exists.
2. What are the main challenges to patent MX2017001331?
Challenges can arise from prior art references demonstrating similar compounds, obviousness arguments, or lack of industrial applicability. Opposition proceedings are rare but possible.
3. Is MX2017001331 enforceable in Mexico?
Yes. The Mexican patent system provides legal mechanisms for patent enforcement, including injunctions and damages, provided the patent is upheld in court.
4. How does the patent landscape influence drug commercialization?
A strong patent provides exclusivity, enabling higher pricing and market control. Patent challenges or invalidations can open opportunities for generic competition.
5. Can the patent be extended beyond its original term?
Extensions are limited in Mexico. However, regulatory delays or the granting of supplementary protection certificates (SPCs) could prolong exclusivity for specific drugs.
References
[1] Mexican Institute of Industrial Property (IMPI). Patent search database. Retrieved 2023.
[2] World Intellectual Property Organization. (2022). Patent Information Services. Retrieved from https://www.wipo.int/patentscope/en
[3] Mexican Healthcare Law. (2021). Intellectual Property and Data Exclusivity Regulations.
